The primary end point is overall survival; secondary end points include progression-free survival, objective response rate, disease control rate, patient-reported outcomes, and assessment of safety and tolerability of ramucirumab.
Rational is presented with non-sentinel node involved rate and number of NSL involved at complementary ALND, axillary recurrence rate, disease free survival rate and adjuvant treatment decision impact.
Secondary endpoints include the 6-month, 12-month, and 18-month OS rates, progression-free survival, and time to progression at second and third progressive disease (PD), response rate, disease control rates, and duration of response at second and third PD.
Subsequently, prevalence ratios were calculated (i.e. prevalence rate disease pair within patients with index-disease/prevalence rate disease pair in patients without index-disease).
Secondary objectives included time to progression (TTP), objective response rate, disease control rate, and tivantinib pharmacokinetics.
Cultivars are bred for functional traits such as rapid growth rate, disease resistance, drought tolerance, and high reproductive output (e.g., seed production, viability, and germination rate) (Fehr 1987).
Accessing subjective symptoms of Japanese cancer patients by self-report has come to be viewed as important as the objective clinical endpoints such as response rate, disease-free survival, and overall survival [18].
This phase II protocol of neoadjuvant chemotherapy with gemcitabine/epirubicin/paclitaxel (GET) was designed to determine the pathologic complete response (pCR) rate in the breast, clinical response rate, disease-free survival, and overall survival at 2 years as well as toxicity in patients with locally advanced breast cancer.
Recommendations like these are particularly critical for those with rate diseases, the founders explain, considering how frequently they are misdiagnosed.
In addition, there was no significant difference in relapse rate, disease-free and overall survival at an average follow-up of 6 years.
Overall, the most common endpoints reported were response rate, disease-free survival (DFS) or progression-free survival (PFS), median OS, recurrence rate, and quality of life.
